(Q21090145)

2

Hiroyuki

Hashizume

1 reference

8 August 2022

Tatsuo Tomishige

3

Tatsuo

Tomishige

1 reference

8 August 2022

Masanori Kawasaki

4

Masanori

Kawasaki

1 reference

8 August 2022

Hidetsugu Tsubouchi

5

Hidetsugu

Tsubouchi

1 reference

8 August 2022

Hirofumi Sasaki

6

Hirofumi

Sasaki

1 reference

8 August 2022

Yoshihiko Shimokawa

7

Yoshihiko

Shimokawa

1 reference

8 August 2022

Makoto Komatsu

8

Makoto

Creative Commons Attribution 4.0 International

Komatsu

1 reference

8 August 2022

language of work or name

English

0 references

publication date

November 2006

0 references

published in

PLOS MEDICINE

0 references

volume

3

0 references

issue

11

0 references

page(s)

e466

0 references

copyright license

start time

28 November 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Nitroheterocyclic drugs with broad spectrum activity

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

The global situation of MDR-TB.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Global tuberculosis incidence and mortality during 1990-2000.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Cytochrome P450 monooxygenases and interactions of psychotropic drugs: a five-year update

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Pharmacokinetic interactions of cimetidine 1987.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Effect of quinidine on the dextromethorphan O-demethylase activity of microsomal fractions from human liver

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Inhibition of human drug metabolizing cytochrome P450 by buprenorphine

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1664607

Screening for novel antituberculosis agents that are effective against multidrug resistant tuberculosis

29 November 2018

1 reference

12 December 2020

In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase

1 reference

12 December 2020

[Studies on the blood level of RFP and new administration method of RFP in relation to other anti-tuberculous drugs]

1 reference

12 December 2020

Pharmacokinetics of antituberculosis drugs in patients

1 reference

12 December 2020

Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8

1 reference

12 December 2020

Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9

1 reference

12 December 2020

Human liver CYP2B6-catalyzed hydroxylation of RP 73401

1 reference

12 December 2020

Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin

1 reference

12 December 2020

TB drug research picks up the pace

1 reference

12 December 2020

10.1371/JOURNAL.PMED.0030466

Identifiers

DOI

1 reference

110015

110015

1 reference

1 reference

1 reference